CLORAZEPATE DIPOTASSIUM

CLORAZEPATE DIPOTASSIUM was reported 1968 times

CLORAZEPATE DIPOTASSIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC PERFUSION DISORDER 7 0.3333
1 PAROXYSMAL CHOREOATHETOSIS 5 0.2778
2 BASAL GANGLION DEGENERATION 21 0.2234
3 HYPOKINETIC DYSARTHRIA 4 0.1333
4 SHIGELLA TEST POSITIVE 2 0.0952
5 TISSUE INFILTRATION 21 0.0712
6 ANAESTHESIA 19 0.0521
7 NEUTROPHIL TOXIC GRANULATION PRESENT 7 0.0464
8 COMA BLISTER 4 0.0444
9 UTERINE ENLARGEMENT 21 0.0264
10 REGRESSIVE BEHAVIOUR 7 0.0241
11 ELECTROMYOGRAM ABNORMAL 4 0.0221
12 CONVULSIVE THRESHOLD LOWERED 8 0.0204
13 PSYCHOGENIC SEIZURE 19 0.0203
14 EYELID MYOCLONUS 2 0.0200
15 HYPOCHROMIC ANAEMIA 19 0.0187
16 LARYNGEAL OBSTRUCTION 3 0.0164
17 OESOPHAGOGASTRIC FUNDOPLASTY 2 0.0118
18 CARDIOACTIVE DRUG LEVEL DECREASED 2 0.0117
19 BLOOD LACTIC ACID DECREASED 2 0.0116
20 PARASOMNIA 8 0.0111
21 GASTROINTESTINAL ARTERIOVENOUS MALFORMATION 3 0.0103
22 ERYTHRODERMIC PSORIASIS 8 0.0097
23 PANCREATIC FAILURE 17 0.0096
24 INTESTINAL VILLI ATROPHY 4 0.0095
25 BOWEL SOUNDS ABNORMAL 3 0.0095
26 TRACHEOBRONCHITIS 7 0.0091
27 ABDOMINAL SEPSIS 8 0.0091
28 NEUROLOGICAL DECOMPENSATION 21 0.0091
29 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6 0.0090
30 PERSISTENT GENITAL AROUSAL DISORDER 2 0.0086
31 BIPOLAR II DISORDER 3 0.0083
32 SLOW SPEECH 20 0.0082
33 PITTING OEDEMA 5 0.0082
34 VICTIM OF CRIME 10 0.0081
35 PHARMACEUTICAL NOMADISM 4 0.0078
36 MITRAL VALVE THICKENING 2 0.0067
37 SOMATIC SYMPTOM DISORDER 7 0.0065
38 CORTISOL INCREASED 4 0.0064
39 STEREOTYPY 6 0.0064
40 NEONATAL ASPIRATION 2 0.0061
41 DYSAESTHESIA 18 0.0059
42 FALLOT'S TETRALOGY 2 0.0058
43 SERUM SEROTONIN INCREASED 2 0.0056
44 WRONG PATIENT RECEIVED PRODUCT 16 0.0055
45 EXTENSOR PLANTAR RESPONSE 5 0.0054
46 NEUROMUSCULAR BLOCK PROLONGED 2 0.0054
47 GASTRITIS HAEMORRHAGIC 8 0.0054
48 REFLUX OESOPHAGITIS 4 0.0053
49 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 2 0.0053
50 PRESCRIPTION FORM TAMPERING 4 0.0052
51 HYPERVENTILATION 30 0.0052
52 OPPOSITIONAL DEFIANT DISORDER 2 0.0051
53 MONOPLEGIA 21 0.0048
54 INTESTINAL PROLAPSE 2 0.0048
55 ACUTE ABDOMEN 7 0.0048
56 PYRAMIDAL TRACT SYNDROME 2 0.0048
57 INTERVERTEBRAL DISC DISORDER 20 0.0047
58 COLONOSCOPY ABNORMAL 2 0.0047
59 FRONTOTEMPORAL DEMENTIA 2 0.0047
60 PRODUCT WITH QUALITY ISSUE ADMINISTERED 2 0.0045
61 HYPERPYREXIA 19 0.0045
62 MUCOSAL EROSION 4 0.0044
63 ABULIA 4 0.0043
64 MASTOCYTOSIS 2 0.0042
65 PATIENT UNCOOPERATIVE 2 0.0042
66 KLEBSIELLA INFECTION 21 0.0041
67 RENAL TUBULAR ACIDOSIS 9 0.0041
68 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 3 0.0040
69 PO2 INCREASED 2 0.0039
70 PULSE PRESSURE DECREASED 2 0.0039
71 SLOW RESPONSE TO STIMULI 5 0.0039
72 FLIGHT OF IDEAS 2 0.0038
73 ABDOMINAL TENDERNESS 19 0.0038
74 ILEUS PARALYTIC 17 0.0038
75 GASTRIC ANTRAL VASCULAR ECTASIA 2 0.0038
76 SCIATIC NERVE NEUROPATHY 2 0.0037
77 HYPOREFLEXIA 7 0.0036
78 INGUINAL HERNIA 22 0.0036
79 AUDITORY DISORDER 5 0.0035
80 GLUTEN SENSITIVITY 5 0.0035
81 MUTISM 5 0.0034
82 DILATATION ATRIAL 4 0.0034
83 HYPOCHLORAEMIA 4 0.0034
84 SJOGREN'S SYNDROME 2 0.0034
85 EXCESSIVE EYE BLINKING 5 0.0034
86 HYPERTENSIVE ENCEPHALOPATHY 2 0.0034
87 HYPERSEXUALITY 6 0.0033
88 LYMPHOCYTOSIS 7 0.0032
89 RAYNAUD'S PHENOMENON 3 0.0032
90 PROTHROMBIN LEVEL DECREASED 3 0.0032
91 INTENTIONAL MISUSE 6 0.0031
92 LYMPHOCELE 2 0.0030
93 DILATED CARDIOMYOPATHY 3 0.0030
94 INFECTIOUS PERITONITIS 2 0.0029
95 HYPOPERFUSION 3 0.0029
96 STUPOR 9 0.0028
97 DERMATITIS EXFOLIATIVE 14 0.0028
98 INFECTION IN AN IMMUNOCOMPROMISED HOST 2 0.0028
99 DYSPNOEA PAROXYSMAL NOCTURNAL 2 0.0027
100 LOBAR PNEUMONIA 5 0.0027
101 APRAXIA 4 0.0027
102 CATATONIA 14 0.0027
103 RENAL CYST 21 0.0026
104 NEGATIVISM 2 0.0026
105 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
106 ATROPHY 5 0.0026
107 CARDIOPULMONARY FAILURE 10 0.0026
108 RESPIRATORY ACIDOSIS 10 0.0025
109 GASTROINTESTINAL OBSTRUCTION 6 0.0025
110 ORGASM ABNORMAL 2 0.0025
111 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
112 ILLUSION 4 0.0024
113 MIOSIS 19 0.0024
114 GAZE PALSY 4 0.0023
115 CHOREA 4 0.0023
116 ALCOHOL WITHDRAWAL SYNDROME 2 0.0023
117 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
118 ANAEMIA OF CHRONIC DISEASE 2 0.0022
119 ARTERIOVENOUS MALFORMATION 2 0.0022
120 ACUTE HEPATIC FAILURE 29 0.0021
121 COR PULMONALE 2 0.0021
122 PCO2 DECREASED 2 0.0021
123 COMA SCALE ABNORMAL 6 0.0021
124 PULMONARY VALVE INCOMPETENCE 3 0.0021
125 PANCREATIC ENZYMES INCREASED 3 0.0020
126 PSYCHIATRIC DECOMPENSATION 4 0.0020
127 POLYDIPSIA 8 0.0020
128 TENDERNESS 21 0.0020
129 DRUG LEVEL ABOVE THERAPEUTIC 9 0.0020
130 COMPULSIVE SHOPPING 4 0.0019
131 BREAST NEOPLASM 2 0.0019
132 AKINESIA 4 0.0019
133 SEROTONIN SYNDROME 37 0.0019
134 JOINT SPRAIN 2 0.0019
135 RESPIRATORY RATE DECREASED 6 0.0019
136 RESPIRATORY DEPRESSION 23 0.0019
137 PULMONARY CONGESTION 24 0.0018
138 RED BLOOD CELL SEDIMENTATION RATE INCREASED 20 0.0018
139 CYTOLYTIC HEPATITIS 6 0.0018
140 CHOLESTATIC LIVER INJURY 4 0.0018
141 DEPRESSED LEVEL OF CONSCIOUSNESS 71 0.0018
142 POISONING DELIBERATE 17 0.0018
143 SPLENOMEGALY 21 0.0018
144 SPINAL PAIN 21 0.0018
145 SOCIAL AVOIDANT BEHAVIOUR 10 0.0017
146 DRUG WITHDRAWAL CONVULSIONS 3 0.0017
147 SUICIDE ATTEMPT 102 0.0017
148 ESCHERICHIA TEST POSITIVE 2 0.0017
149 HYPERCAPNIA 5 0.0017
150 MUSCLE SPASTICITY 20 0.0016
151 INTENTIONAL OVERDOSE 104 0.0016
152 MULTIPLE DRUG OVERDOSE 8 0.0016
153 HYPOPROTEINAEMIA 3 0.0016
154 CAROTID ARTERY DISEASE 2 0.0016
155 LIP HAEMORRHAGE 2 0.0016
156 SHOCK 36 0.0016
157 METABOLIC ACIDOSIS 50 0.0016
158 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
159 CEREBRAL ATROPHY 6 0.0015
160 AREFLEXIA 4 0.0015
161 ANION GAP INCREASED 2 0.0015
162 HEPATITIS CHOLESTATIC 9 0.0015
163 COMA 71 0.0015
164 BRADYPNOEA 4 0.0015
165 MYDRIASIS 19 0.0015
166 DIFFICULTY IN WALKING 5 0.0015
167 HAEMODYNAMIC INSTABILITY 11 0.0014
168 OBESITY 23 0.0014
169 URINARY BLADDER HAEMORRHAGE 3 0.0014
170 PSYCHOMOTOR RETARDATION 4 0.0014
171 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
172 AORTIC VALVE INCOMPETENCE 6 0.0014
173 PORPHYRIA ACUTE 2 0.0014
174 FACIAL PALSY 3 0.0014
175 HYPOKINESIA 20 0.0014
176 ELECTROLYTE IMBALANCE 16 0.0014
177 BIPOLAR I DISORDER 3 0.0014
178 AFFECT LABILITY 13 0.0013
179 PNEUMONIA PNEUMOCOCCAL 2 0.0013
180 ANGIOPLASTY 2 0.0013
181 HYPOAESTHESIA FACIAL 2 0.0013
182 MYOCLONIC EPILEPSY 2 0.0013
183 SLEEP APNOEA SYNDROME 25 0.0013
184 DRUG ABUSER 8 0.0013
185 MULTIPLE-DRUG RESISTANCE 4 0.0013
186 FAMILY STRESS 4 0.0013
187 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
188 ATAXIA 15 0.0013
189 SEDATION 33 0.0013
190 WEIGHT ABNORMAL 3 0.0012
191 INTRA-UTERINE DEATH 2 0.0012
192 CANDIDA INFECTION 21 0.0012
193 HEPATIC STEATOSIS 23 0.0012
194 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
195 HEPATITIS ACUTE 8 0.0012
196 LEUKOCYTOCLASTIC VASCULITIS 2 0.0012
197 BRADYPHRENIA 8 0.0012
198 DELUSION 19 0.0012
199 PSYCHOMOTOR HYPERACTIVITY 20 0.0012
200 THERAPEUTIC AGENT TOXICITY 4 0.0012
201 VENTRICULAR HYPERTROPHY 3 0.0012
202 HAEMODIALYSIS 10 0.0012
203 EXCORIATION 3 0.0012
204 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
205 NEUROPATHY 2 0.0012
206 CHOLECYSTITIS 14 0.0012
207 EUPHORIC MOOD 12 0.0012
208 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
209 HYPERREFLEXIA 4 0.0011
210 PARTIAL SEIZURES 6 0.0011
211 PRODUCT PHYSICAL ISSUE 23 0.0011
212 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
213 ALCOHOL POISONING 3 0.0011
214 BLOOD SODIUM INCREASED 3 0.0011
215 OBSESSIVE THOUGHTS 2 0.0011
216 BEHAVIOUR DISORDER 6 0.0011
217 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
218 ESSENTIAL HYPERTENSION 2 0.0011
219 MYOCLONUS 13 0.0011
220 INCOHERENT 7 0.0011
221 ENDOTRACHEAL INTUBATION 3 0.0011
222 INTERVERTEBRAL DISCITIS 2 0.0011
223 SNORING 4 0.0011
224 BLOOD BICARBONATE DECREASED 2 0.0011
225 ECONOMIC PROBLEM 16 0.0011
226 STEVENS-JOHNSON SYNDROME 23 0.0010
227 DRUG LEVEL INCREASED 17 0.0010
228 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
229 HYPERTRANSAMINASAEMIA 7 0.0010
230 BRAIN HERNIATION 3 0.0010
231 CANDIDIASIS 4 0.0010
232 TOXIC ENCEPHALOPATHY 5 0.0010
233 PSYCHOTIC SYMPTOM 2 0.0010
234 HYPERTHYROIDISM 14 0.0010
235 COAGULOPATHY 16 0.0010
236 DILATATION VENTRICULAR 2 0.0010
237 INFUSION SITE PRURITUS 3 0.0009
238 SUDDEN DEATH 10 0.0009
239 ORTHOPNOEA 3 0.0009
240 DRUG ABUSE 78 0.0009
241 VENTRICULAR HYPOKINESIA 3 0.0009
242 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
243 REACTION TO DRUG EXCIPIENTS 2 0.0009
244 CEREBELLAR SYNDROME 2 0.0009
245 DISORIENTATION 36 0.0009
246 MIDDLE EAR EFFUSION 2 0.0009
247 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
248 AFFECTIVE DISORDER 7 0.0009
249 HAEMATOMA 23 0.0009
250 TRICUSPID VALVE INCOMPETENCE 7 0.0009
251 SUDDEN CARDIAC DEATH 3 0.0009
252 HYPOTHYROIDISM 28 0.0009
253 POISONING 11 0.0009
254 CERVICAL VERTEBRAL FRACTURE 3 0.0009
255 CAROTID ARTERY STENOSIS 3 0.0009
256 BILIRUBIN CONJUGATED INCREASED 2 0.0009
257 POLYURIA 7 0.0009
258 LONG QT SYNDROME 2 0.0008
259 ORAL INTAKE REDUCED 2 0.0008
260 RESTLESSNESS 30 0.0008
261 LUNG DISORDER 40 0.0008
262 HYPOMANIA 3 0.0008
263 SPRUE-LIKE ENTEROPATHY 4 0.0008
264 ACUTE PSYCHOSIS 2 0.0008
265 INFREQUENT BOWEL MOVEMENTS 2 0.0008
266 HYPOTONIA 8 0.0008
267 PROTEIN TOTAL DECREASED 3 0.0008
268 DRUG INTERACTION 126 0.0008
269 HEPATOSPLENOMEGALY 2 0.0008
270 MENOPAUSE 2 0.0008
271 PERIPHERAL VASCULAR DISORDER 4 0.0008
272 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
273 PERSONALITY DISORDER 2 0.0008
274 PSYCHOMOTOR SKILLS IMPAIRED 2 0.0008
275 DRUG SCREEN POSITIVE 6 0.0008
276 RADICULOPATHY 2 0.0008
277 NEUROLEPTIC MALIGNANT SYNDROME 9 0.0008
278 GRAND MAL CONVULSION 7 0.0008
279 HYPERLIPIDAEMIA 9 0.0008
280 OESOPHAGEAL CANDIDIASIS 3 0.0008
281 AZOTAEMIA 3 0.0008
282 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
283 BLOOD PHOSPHORUS INCREASED 2 0.0007
284 RESPIRATORY TRACT INFECTION 19 0.0007
285 DRUG SCREEN FALSE POSITIVE 2 0.0007
286 RASH MORBILLIFORM 2 0.0007
287 ON AND OFF PHENOMENON 4 0.0007
288 CONGESTIVE CARDIOMYOPATHY 3 0.0007
289 PROCTITIS 2 0.0007
290 MITRAL VALVE INCOMPETENCE 8 0.0007
291 CHOLECYSTITIS ACUTE 4 0.0007
292 FEBRILE BONE MARROW APLASIA 3 0.0007
293 JOINT LOCK 2 0.0007
294 ALCOHOLISM 3 0.0007
295 SALIVARY HYPERSECRETION 7 0.0007
296 AGRANULOCYTOSIS 13 0.0007
297 VENTRICULAR SEPTAL DEFECT 4 0.0007
298 HYPOGLYCAEMIC COMA 2 0.0007
299 HYPOTHERMIA 7 0.0007
300 RALES 4 0.0007
301 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
302 PNEUMONIA ASPIRATION 17 0.0007
303 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
304 FEAR 18 0.0007
305 METABOLIC ENCEPHALOPATHY 2 0.0007
306 SOMNOLENCE 134 0.0007
307 TACHYPNOEA 9 0.0007
308 REBOUND ACID HYPERSECRETION 2 0.0007
309 VIRAL INFECTION 22 0.0007
310 CRANIOCEREBRAL INJURY 2 0.0007
311 DRUG TOXICITY 9 0.0007
312 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
313 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
314 DUODENITIS 2 0.0007
315 RENAL FAILURE CHRONIC 5 0.0006
316 BRAIN DEATH 2 0.0006
317 HEPATIC ENCEPHALOPATHY 6 0.0006
318 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
319 RENAL FAILURE ACUTE 27 0.0006
320 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
321 MULTIPLE INJURIES 4 0.0006
322 FOREIGN BODY IN THROAT 2 0.0006
323 RESPIRATORY FAILURE 46 0.0006
324 EOSINOPHILIA 11 0.0006
325 SENSORY DISTURBANCE 10 0.0006
326 MULTIPLE DRUG OVERDOSE INTENTIONAL 2 0.0006
327 RASH VESICULAR 3 0.0006
328 SUBSTANCE ABUSE 5 0.0006
329 DECUBITUS ULCER 5 0.0006
330 RENAL TUBULAR NECROSIS 6 0.0006
331 DIABETIC NEUROPATHY 3 0.0006
332 OTITIS MEDIA 2 0.0006
333 HYPONATRAEMIA 34 0.0006
334 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
335 CORONARY ARTERY STENOSIS 3 0.0006
336 TACHYCARDIA 53 0.0006
337 HYPOXIA 21 0.0006
338 CONVULSION 34 0.0006
339 LYMPHADENOPATHY 21 0.0006
340 SPEECH DISORDER 31 0.0006
341 DYSLIPIDAEMIA 3 0.0006
342 BLISTER 33 0.0006
343 AKATHISIA 8 0.0006
344 EYE MOVEMENT DISORDER 4 0.0006
345 WRIST FRACTURE 7 0.0006
346 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
347 JOINT EFFUSION 4 0.0006
348 DEPRESSION SUICIDAL 2 0.0006
349 MICTURITION DISORDER 2 0.0006
350 ACUTE RESPIRATORY FAILURE 11 0.0006
351 FOOD CRAVING 3 0.0006
352 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
353 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
354 HAND FRACTURE 4 0.0006
355 FIBRIN D DIMER INCREASED 2 0.0006
356 BRUXISM 3 0.0006
357 DERMATITIS BULLOUS 4 0.0006
358 HAEMATEMESIS 14 0.0006
359 HYPERGLYCAEMIA 20 0.0005
360 INTENTIONAL SELF-INJURY 11 0.0005
361 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
362 VENTRICULAR FIBRILLATION 6 0.0005
363 URINARY RETENTION 18 0.0005
364 SEIZURE 62 0.0005
365 STATUS EPILEPTICUS 6 0.0005
366 HEPATIC NECROSIS 2 0.0005
367 NEUROLOGICAL SYMPTOM 3 0.0005
368 ATELECTASIS 5 0.0005
369 PANIC DISORDER 2 0.0005
370 APNOEA 4 0.0005
371 URINE ODOUR ABNORMAL 3 0.0005
372 HEAD INJURY 16 0.0005
373 TOXICITY TO VARIOUS AGENTS 85 0.0005
374 GINGIVAL PAIN 4 0.0005
375 MUSCLE RIGIDITY 6 0.0005
376 HYPERPHAGIA 2 0.0005
377 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
378 ENURESIS 2 0.0005
379 TRANSAMINASES INCREASED 11 0.0005
380 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
381 SINUS TACHYCARDIA 7 0.0005
382 MOTOR DYSFUNCTION 5 0.0005
383 ASPHYXIA 4 0.0005
384 PERIPHERAL ISCHAEMIA 2 0.0005
385 GOITRE 2 0.0005
386 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
387 CHOLANGITIS 3 0.0005
388 OLIGURIA 3 0.0005
389 ACUTE CORONARY SYNDROME 4 0.0005
390 CONFUSIONAL STATE 78 0.0005
391 SLEEP DISORDER 34 0.0005
392 PETECHIAE 5 0.0005
393 NERVOUSNESS 25 0.0005
394 AGITATION 35 0.0005
395 SCREAMING 3 0.0005
396 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
397 ANURIA 4 0.0005
398 BIPOLAR DISORDER 5 0.0005
399 ONYCHOMYCOSIS 2 0.0005
400 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
401 CATHETERISATION CARDIAC 2 0.0005
402 HYPERTENSIVE CRISIS 5 0.0004
403 COLITIS ISCHAEMIC 3 0.0004
404 IRON DEFICIENCY 2 0.0004
405 BONE PAIN 26 0.0004
406 MYOCARDIAL ISCHAEMIA 5 0.0004
407 ABDOMINAL HERNIA 2 0.0004
408 RESPIRATORY DISORDER 13 0.0004
409 DROOLING 3 0.0004
410 IRON DEFICIENCY ANAEMIA 4 0.0004
411 NEPHROGENIC ANAEMIA 2 0.0004
412 COORDINATION ABNORMAL 6 0.0004
413 ROSACEA 2 0.0004
414 WITHDRAWAL SYNDROME 18 0.0004
415 MANIA 7 0.0004
416 VENTRICULAR TACHYCARDIA 7 0.0004
417 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
418 GASTRIC ULCER 8 0.0004
419 SUBDURAL HAEMATOMA 6 0.0004
420 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
421 HYPOVOLAEMIC SHOCK 2 0.0004
422 BRADYCARDIA 22 0.0004
423 HYPERHIDROSIS 53 0.0004
424 MAJOR DEPRESSION 3 0.0004
425 RENAL CELL CARCINOMA 2 0.0004
426 DISTURBANCE IN ATTENTION 22 0.0004
427 INFLAMMATION 21 0.0004
428 CARDIOMEGALY 5 0.0004
429 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
430 BREATH SOUNDS ABNORMAL 2 0.0004
431 MULTI-ORGAN FAILURE 7 0.0004
432 SUICIDAL IDEATION 37 0.0004
433 HYPERNATRAEMIA 2 0.0004
434 PANCREATITIS ACUTE 9 0.0004
435 LEUKOPENIA 20 0.0004
436 RESPIRATORY DISTRESS 11 0.0004
437 ANAPHYLACTIC REACTION 22 0.0004
438 TOXIC SKIN ERUPTION 4 0.0004
439 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
440 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
441 DRUG TOLERANCE 2 0.0004
442 DYSPHORIA 2 0.0004
443 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
444 DRUG LEVEL DECREASED 4 0.0004
445 HYPERTHERMIA 3 0.0004
446 LIPASE INCREASED 3 0.0004
447 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
448 ENDOCARDITIS 2 0.0004
449 DYSPHAGIA 37 0.0004
450 PRODUCT COLOUR ISSUE 2 0.0004
451 ANOREXIA 5 0.0004
452 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
453 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
454 RHABDOMYOLYSIS 16 0.0004
455 APLASTIC ANAEMIA 2 0.0004
456 SERUM FERRITIN INCREASED 2 0.0004
457 JOINT DISLOCATION 4 0.0004
458 DELIRIUM 13 0.0004
459 STENT PLACEMENT 3 0.0004
460 CHOLELITHIASIS 12 0.0004
461 NONSPECIFIC REACTION 2 0.0004
462 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
463 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
464 HEMIPLEGIA 3 0.0004
465 ANGIOPATHY 2 0.0004
466 COLECTOMY 2 0.0004
467 CIRCULATORY COLLAPSE 6 0.0004
468 HEPATITIS 9 0.0004
469 NEUTROPHILIA 2 0.0004
470 CARDIAC VALVE DISEASE 2 0.0003
471 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
472 HYPERTONIA 2 0.0003
473 MYOCARDITIS 4 0.0003
474 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
475 DYSKINESIA 14 0.0003
476 HYPERTRIGLYCERIDAEMIA 2 0.0003
477 SPINAL OSTEOARTHRITIS 3 0.0003
478 DECREASED INTEREST 2 0.0003
479 PURPURA 3 0.0003
480 CARDIOTOXICITY 3 0.0003
481 PROTHROMBIN TIME PROLONGED 2 0.0003
482 POLYNEUROPATHY 4 0.0003
483 HEARING IMPAIRED 2 0.0003
484 SEPSIS 37 0.0003
485 LEUKOCYTOSIS 6 0.0003
486 RENAL FAILURE 44 0.0003
487 APHASIA 10 0.0003
488 EPILEPSY 10 0.0003
489 ACUTE KIDNEY INJURY 50 0.0003
490 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
491 NERVE COMPRESSION 3 0.0003
492 HYPOKALAEMIA 15 0.0003
493 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
494 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
495 SCOLIOSIS 2 0.0003
496 EXTRAPYRAMIDAL DISORDER 8 0.0003
497 COGNITIVE DISORDER 15 0.0003
498 FLANK PAIN 3 0.0003
499 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
500 LOSS OF CONSCIOUSNESS 41 0.0003
501 GENERAL PHYSICAL HEALTH DETERIORATION 37 0.0003
502 NASAL DRYNESS 2 0.0003
503 LACERATION 3 0.0003
504 DYSARTHRIA 12 0.0003
505 ARTERIOSCLEROSIS 3 0.0003
506 INFUSION SITE SWELLING 2 0.0003
507 ARRHYTHMIA 15 0.0003
508 OVERDOSE 68 0.0003
509 HALLUCINATION, AUDITORY 5 0.0003
510 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
511 THROMBOCYTOPENIA 35 0.0003
512 CHOLESTASIS 6 0.0003
513 LOWER LIMB FRACTURE 6 0.0003
514 CARDIO-RESPIRATORY ARREST 13 0.0003
515 DRUG INTOLERANCE 30 0.0003
516 ANXIETY 88 0.0003
517 ANGINA UNSTABLE 2 0.0003
518 PARKINSONISM 3 0.0003
519 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
520 CHOKING 6 0.0003
521 TREMOR 51 0.0003
522 OSTEOARTHRITIS 13 0.0003
523 HEPATOMEGALY 3 0.0003
524 LABORATORY TEST ABNORMAL 9 0.0003
525 PANCYTOPENIA 17 0.0003
526 GASTRITIS 8 0.0003
527 ANKYLOSING SPONDYLITIS 4 0.0003
528 CHOLECYSTITIS CHRONIC 2 0.0003
529 BLOOD UREA INCREASED 5 0.0003
530 OEDEMA PERIPHERAL 36 0.0003
531 UVEITIS 4 0.0003
532 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
533 HYPOTENSION 59 0.0003
534 PALLOR 8 0.0003
535 URINARY TRACT INFECTION 50 0.0003
536 HYPERBILIRUBINAEMIA 3 0.0003
537 ENCEPHALITIS 2 0.0003
538 CARPAL TUNNEL SYNDROME 4 0.0003
539 LIVER INJURY 7 0.0003
540 SCRATCH 3 0.0003
541 DEVICE OCCLUSION 4 0.0003
542 INCONTINENCE 3 0.0003
543 AGGRESSION 14 0.0003
544 GRAFT VERSUS HOST DISEASE 2 0.0003
545 ABNORMAL BEHAVIOUR 11 0.0003
546 PANIC REACTION 2 0.0003
547 OESOPHAGITIS 3 0.0003
548 APATHY 4 0.0003
549 ASPIRATION 3 0.0003
550 DRUG WITHDRAWAL SYNDROME 24 0.0003
551 MOUTH HAEMORRHAGE 2 0.0003
552 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
553 FALL 90 0.0003
554 CONJUNCTIVITIS 5 0.0003
555 FEELING DRUNK 2 0.0003
556 INTESTINAL OBSTRUCTION 10 0.0003
557 PAROSMIA 2 0.0003
558 NEUTROPENIA 36 0.0003
559 OSTEOPENIA 4 0.0003
560 INSURANCE ISSUE 4 0.0003
561 DISSOCIATION 2 0.0003
562 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
563 LETHARGY 15 0.0003
564 GASTRIC HAEMORRHAGE 3 0.0003
565 BLOOD CREATININE INCREASED 17 0.0003
566 THYROID DISORDER 4 0.0003
567 BLOOD BILIRUBIN INCREASED 7 0.0003
568 BLOOD CHOLESTEROL INCREASED 12 0.0003
569 EJECTION FRACTION DECREASED 4 0.0003
570 PELVIC FRACTURE 2 0.0003
571 MOOD ALTERED 7 0.0003
572 HYPERKALAEMIA 9 0.0003
573 DEVICE MALFUNCTION 18 0.0003
574 DEPRESSION 58 0.0003
575 NEOPLASM MALIGNANT 17 0.0003
576 CYANOSIS 4 0.0003
577 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
578 COMPLETED SUICIDE 21 0.0003
579 FEELING COLD 7 0.0003
580 ATRIAL FLUTTER 2 0.0003
581 PRESCRIBED UNDERDOSE 5 0.0003
582 DEMENTIA 7 0.0003
583 IRRITABILITY 15 0.0002
584 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
585 SENSORY LOSS 2 0.0002
586 C-REACTIVE PROTEIN INCREASED 9 0.0002
587 MUSCLE DISORDER 2 0.0002
588 SCHIZOPHRENIA 3 0.0002
589 ABNORMAL FAECES 2 0.0002
590 ESCHERICHIA INFECTION 2 0.0002
591 OSTEOPOROSIS 10 0.0002
592 HYPERCALCAEMIA 3 0.0002
593 INTENTIONAL DRUG MISUSE 5 0.0002
594 ATRIAL SEPTAL DEFECT 2 0.0002
595 SENSATION OF FOREIGN BODY 2 0.0002
596 PSYCHOTIC DISORDER 7 0.0002
597 HALLUCINATION, VISUAL 5 0.0002
598 ANAEMIA 45 0.0002
599 FACIAL PARALYSIS 2 0.0002
600 UNRESPONSIVE TO STIMULI 6 0.0002
601 OXYGEN SATURATION DECREASED 13 0.0002
602 CORONARY ARTERY DISEASE 7 0.0002
603 CARDIAC MURMUR 2 0.0002
604 DEEP VEIN THROMBOSIS 15 0.0002
605 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
606 INSOMNIA 61 0.0002
607 FEMUR FRACTURE 7 0.0002
608 EAR INFECTION 6 0.0002
609 THIRST 4 0.0002
610 FREQUENT BOWEL MOVEMENTS 6 0.0002
611 GASTROENTERITIS VIRAL 4 0.0002
612 CONDITION AGGRAVATED 67 0.0002
613 MUSCULAR WEAKNESS 25 0.0002
614 PRODUCT AVAILABILITY ISSUE 5 0.0002
615 EXOSTOSIS 2 0.0002
616 INCREASED TENDENCY TO BRUISE 2 0.0002
617 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
618 DIVERTICULITIS 6 0.0002
619 LYMPHOPENIA 3 0.0002
620 SEASONAL ALLERGY 3 0.0002
621 CONSTIPATION 46 0.0002
622 PROTEINURIA 4 0.0002
623 DEHYDRATION 28 0.0002
624 RECTAL HAEMORRHAGE 9 0.0002
625 INCREASED APPETITE 4 0.0002
626 HYPERSOMNIA 6 0.0002
627 PRODUCT SUBSTITUTION ISSUE 12 0.0002
628 POST PROCEDURAL COMPLICATION 4 0.0002
629 HYPERCHOLESTEROLAEMIA 2 0.0002
630 HYPOAESTHESIA 31 0.0002
631 PRESCRIBED OVERDOSE 4 0.0002
632 FLUID OVERLOAD 3 0.0002
633 CARDIAC ARREST 17 0.0002
634 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
635 EAR PAIN 4 0.0002
636 GASTROENTERITIS 3 0.0002
637 AUTOIMMUNE DISORDER 2 0.0002
638 HAEMORRHOIDS 4 0.0002
639 BODY TEMPERATURE DECREASED 2 0.0002
640 BLADDER DISORDER 2 0.0002
641 PULMONARY OEDEMA 9 0.0002
642 OVARIAN CYST 2 0.0002
643 MYALGIA 34 0.0002
644 HALLUCINATION 15 0.0002
645 HEPATIC FAILURE 6 0.0002
646 GAIT DISTURBANCE 38 0.0002
647 EMPHYSEMA 2 0.0002
648 PRODUCT ADMINISTRATION ERROR 4 0.0002
649 PNEUMONIA 64 0.0002
650 PAIN IN EXTREMITY 58 0.0002
651 PYREXIA 68 0.0002
652 RIB FRACTURE 4 0.0002
653 POOR VENOUS ACCESS 2 0.0002
654 BRAIN FOG 3 0.0002
655 DIZZINESS 95 0.0002
656 ANHEDONIA 5 0.0002
657 KNEE ARTHROPLASTY 4 0.0002
658 SYNCOPE 19 0.0002
659 RESPIRATORY TRACT CONGESTION 3 0.0002
660 PRODUCTIVE COUGH 9 0.0002
661 JOINT INJURY 4 0.0002
662 CARDIAC FAILURE CONGESTIVE 15 0.0002
663 HEREDITARY ANGIOEDEMA 2 0.0002
664 INTERSTITIAL LUNG DISEASE 9 0.0002
665 DYSPNOEA EXERTIONAL 7 0.0002
666 JAUNDICE 5 0.0002
667 VOMITING 87 0.0002
668 CHRONIC KIDNEY DISEASE 14 0.0002
669 ABDOMINAL DISTENSION 19 0.0002
670 PHOTOSENSITIVITY REACTION 3 0.0002
671 RESPIRATORY ARREST 5 0.0002
672 MENTAL STATUS CHANGES 5 0.0002
673 MEDICATION ERROR 10 0.0002
674 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
675 NECK PAIN 10 0.0002
676 GASTROINTESTINAL DISORDER 16 0.0002
677 TYPE 2 DIABETES MELLITUS 6 0.0002
678 TARDIVE DYSKINESIA 5 0.0002
679 HEMIPARESIS 3 0.0002
680 NAUSEA 139 0.0002
681 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
682 CHOLECYSTECTOMY 2 0.0002
683 NEPHROLITHIASIS 8 0.0002
684 BALANCE DISORDER 15 0.0002
685 MUSCLE TWITCHING 4 0.0002
686 EMOTIONAL DISTRESS 21 0.0002
687 EXTRA DOSE ADMINISTERED 7 0.0002
688 CHEST PAIN 32 0.0002
689 ORTHOSTATIC HYPOTENSION 3 0.0002
690 BACK PAIN 40 0.0002
691 NEUTROPHIL COUNT DECREASED 7 0.0002
692 INTENTIONAL PRODUCT MISUSE 15 0.0002
693 METASTASES TO LIVER 3 0.0002
694 ACUTE MYOCARDIAL INFARCTION 5 0.0002
695 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
696 PLATELET COUNT DECREASED 18 0.0002
697 RENAL INJURY 5 0.0002
698 NEUROPATHY PERIPHERAL 16 0.0002
699 VISION BLURRED 23 0.0002
700 BLOOD PRESSURE DECREASED 11 0.0002
701 NOCTURIA 2 0.0002
702 PANIC ATTACK 6 0.0002
703 NEURALGIA 4 0.0002
704 TREATMENT NONCOMPLIANCE 9 0.0002
705 END STAGE RENAL DISEASE 3 0.0002
706 VERTIGO 10 0.0002
707 DRUG ADMINISTRATION ERROR 5 0.0002
708 BRONCHITIS 12 0.0002
709 CYST 2 0.0002
710 MENTAL DISORDER 7 0.0002
711 MIDDLE INSOMNIA 3 0.0002
712 NERVOUS SYSTEM DISORDER 5 0.0002
713 DRUG-INDUCED LIVER INJURY 5 0.0002
714 HOT FLUSH 12 0.0002
715 BLOOD SODIUM DECREASED 3 0.0002
716 DERMATITIS ALLERGIC 2 0.0002
717 HYPOCALCAEMIA 3 0.0002
718 BRAIN OEDEMA 2 0.0002
719 CARDIOVASCULAR DISORDER 4 0.0002
720 FEELING JITTERY 3 0.0002
721 INJECTION SITE IRRITATION 2 0.0002
722 CYSTITIS 5 0.0002
723 HEPATIC CYTOLYSIS 2 0.0002
724 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
725 ROTATOR CUFF SYNDROME 2 0.0002
726 MOVEMENT DISORDER 5 0.0002
727 HERNIA 3 0.0002
728 DYSTONIA 3 0.0002
729 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
730 AMNESIA 10 0.0002
731 MUCOSAL INFLAMMATION 4 0.0002
732 BEDRIDDEN 2 0.0002
733 ORAL CANDIDIASIS 2 0.0002
734 STAPHYLOCOCCAL INFECTION 5 0.0002
735 SINUS DISORDER 3 0.0002
736 SOPOR 2 0.0002
737 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
738 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
739 SINUS CONGESTION 2 0.0001
740 FEEDING DISORDER 3 0.0001
741 BONE MARROW FAILURE 3 0.0001
742 PULMONARY EMBOLISM 14 0.0001
743 DIARRHOEA 95 0.0001
744 IMPAIRED GASTRIC EMPTYING 2 0.0001
745 ASTHENIA 55 0.0001
746 HAEMATURIA 5 0.0001
747 CORONARY ARTERY OCCLUSION 2 0.0001
748 SKIN LESION 4 0.0001
749 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
750 PERIPHERAL COLDNESS 2 0.0001
751 ILLNESS 15 0.0001
752 UNEVALUABLE EVENT 11 0.0001
753 CHILLS 17 0.0001
754 TREATMENT FAILURE 12 0.0001
755 HYPOGLYCAEMIA 7 0.0001
756 WOUND 4 0.0001
757 HEADACHE 89 0.0001
758 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
759 ERYTHEMA 29 0.0001
760 EATING DISORDER 3 0.0001
761 DRY EYE 7 0.0001
762 BRONCHOSPASM 2 0.0001
763 IRRITABLE BOWEL SYNDROME 3 0.0001
764 ANGINA PECTORIS 4 0.0001
765 POOR QUALITY SLEEP 3 0.0001
766 SKIN CANCER 3 0.0001
767 MOBILITY DECREASED 10 0.0001
768 FAECES DISCOLOURED 3 0.0001
769 ANOSMIA 2 0.0001
770 INJECTION SITE HAEMATOMA 2 0.0001
771 PRODUCT DISPENSING ERROR 3 0.0001
772 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
773 DRUG DEPENDENCE 22 0.0001
774 ABDOMINAL PAIN UPPER 28 0.0001
775 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
776 HEPATOTOXICITY 3 0.0001
777 COLON CANCER 2 0.0001
778 PANCREATITIS 7 0.0001
779 ILL-DEFINED DISORDER 8 0.0001
780 DEVICE FAILURE 2 0.0001
781 DIABETES MELLITUS 10 0.0001
782 OFF LABEL USE 114 0.0001
783 PHARYNGEAL OEDEMA 2 0.0001
784 PERICARDIAL EFFUSION 3 0.0001
785 BASAL CELL CARCINOMA 2 0.0001
786 PRODUCT USE COMPLAINT 2 0.0001
787 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
788 COUGH 35 0.0001
789 ABORTION SPONTANEOUS 5 0.0001
790 CONTUSION 12 0.0001
791 MEMORY IMPAIRMENT 17 0.0001
792 DYSPNOEA 70 0.0001
793 DRY MOUTH 10 0.0001
794 BACK DISORDER 2 0.0001
795 BLINDNESS 5 0.0001
796 ENCEPHALOPATHY 3 0.0001
797 WEIGHT DECREASED 34 0.0001
798 ABASIA 3 0.0001
799 HEART RATE INCREASED 12 0.0001
800 FEELING ABNORMAL 29 0.0001
801 VISUAL ACUITY REDUCED 4 0.0001
802 ABDOMINAL PAIN 28 0.0001
803 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
804 FATIGUE 92 0.0001
805 ARTHRALGIA 49 0.0001
806 PRODUCT QUALITY ISSUE 16 0.0001
807 HYPOPHAGIA 3 0.0001
808 CHEST DISCOMFORT 12 0.0001
809 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
810 HAEMOGLOBIN DECREASED 12 0.0001
811 ERECTILE DYSFUNCTION 3 0.0001
812 SCAR 2 0.0001
813 ANAPHYLACTIC SHOCK 3 0.0001
814 MUSCULOSKELETAL DISCOMFORT 2 0.0001
815 PARANOIA 2 0.0001
816 PRODUCT DOSE OMISSION ISSUE 34 0.0001
817 NIGHTMARE 4 0.0001
818 SEPTIC SHOCK 5 0.0001
819 PRURITUS 44 0.0001
820 INJURY 8 0.0001
821 ANGIOEDEMA 5 0.0001
822 HEAD DISCOMFORT 2 0.0001
823 GALLBLADDER DISORDER 2 0.0001
824 THROMBOSIS 9 0.0001
825 WEIGHT INCREASED 25 0.0001
826 PALPITATIONS 13 0.0001
827 LIMB INJURY 3 0.0001
828 RESTLESS LEGS SYNDROME 2 0.0001
829 ABNORMAL DREAMS 3 0.0001
830 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
831 ARTHROPATHY 6 0.0001
832 RASH 47 0.0001
833 EPISTAXIS 8 0.0001
834 CEREBROVASCULAR ACCIDENT 18 0.0001
835 FRACTURE 2 0.0001
836 COLITIS 4 0.0001
837 DISEASE RECURRENCE 5 0.0001
838 BLOOD PRESSURE INCREASED 16 0.0001
839 MULTIPLE SCLEROSIS 5 0.0001
840 ERUCTATION 2 0.0001
841 DYSSTASIA 3 0.0001
842 PAIN 63 0.0001
843 ORAL HERPES 2 0.0001
844 ASCITES 3 0.0001
845 KIDNEY INFECTION 2 0.0001
846 PARAESTHESIA 16 0.0001
847 ABDOMINAL DISCOMFORT 17 0.0001
848 URINARY INCONTINENCE 3 0.0001
849 WHEEZING 6 0.0001
850 DISABILITY 2 0.0001
851 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
852 CATARACT 6 0.0001
853 COMPLICATION OF DEVICE INSERTION 2 0.0001
854 MUSCLE SPASMS 18 0.0001
855 BODY TEMPERATURE INCREASED 2 0.0001
856 HOSPITALISATION 15 0.0001
857 THERAPY CESSATION 5 0.0001
858 VISUAL IMPAIRMENT 12 0.0001
859 PERITONITIS 2 0.0001
860 CARDIAC DISORDER 9 0.0001
861 SWOLLEN TONGUE 3 0.0001
862 POLLAKIURIA 4 0.0001
863 BONE DENSITY DECREASED 3 0.0001
864 DRUG INEFFECTIVE 126 0.0001
865 DEPRESSED MOOD 5 0.0001
866 MIGRAINE 9 0.0001
867 HYPOACUSIS 4 0.0001
868 RHINORRHOEA 6 0.0001
869 LACTIC ACIDOSIS 3 0.0001
870 ATRIAL FIBRILLATION 9 0.0001
871 RASH PRURITIC 5 0.0001
872 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
873 MELAENA 2 0.0001
874 DECREASED APPETITE 21 0.0001
875 LIP SWELLING 3 0.0001
876 RASH MACULO-PAPULAR 2 0.0001
877 GAIT INABILITY 3 0.0001
878 HYPERTENSION 19 0.0001
879 EYE PRURITUS 3 0.0001
880 RASH PAPULAR 2 0.0001
881 SNEEZING 2 0.0001
882 ARTHRITIS 7 0.0001
883 FLATULENCE 5 0.0001
884 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
885 GASTRIC DISORDER 3 0.0001
886 TINNITUS 4 0.0001
887 RENAL DISORDER 4 0.0001
888 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
889 HEART RATE DECREASED 3 0.0001
890 OCULAR HYPERAEMIA 4 0.0001
891 RASH ERYTHEMATOUS 4 0.0001
892 BLOOD PRESSURE FLUCTUATION 2 0.0001
893 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
894 MENTAL IMPAIRMENT 2 0.0001
895 FIBROMYALGIA 2 0.0001
896 PRESYNCOPE 2 0.0001
897 UNDERDOSE 6 0.0001
898 PLEURAL EFFUSION 5 0.0001
899 ACCIDENTAL OVERDOSE 3 0.0001
900 DYSURIA 3 0.0001
901 MYOCARDIAL INFARCTION 14 0.0001
902 ADVERSE DRUG REACTION 7 0.0001
903 URTICARIA 13 0.0001
904 MALAISE 34 0.0001
905 RASH GENERALISED 2 0.0001
906 JOINT STIFFNESS 2 0.0001
907 HYPERSENSITIVITY 14 0.0001
908 BREAST CANCER FEMALE 2 0.0001
909 SWELLING 7 0.0001
910 BLOOD GLUCOSE INCREASED 14 0.0001
911 OEDEMA 4 0.0001
912 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
913 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
914 SKIN EXFOLIATION 6 0.0001
915 PAIN IN JAW 2 0.0001
916 THERAPY INTERRUPTED 5 0.0001
917 RED BLOOD CELL COUNT DECREASED 2 0.0001
918 HERPES ZOSTER 4 0.0001
919 INFECTION 10 0.0001
920 FLUSHING 7 0.0001
921 LIVER FUNCTION TEST ABNORMAL 2 0.0001
922 DYSPHONIA 4 0.0001
923 SURGERY 4 0.0001
924 LIVER DISORDER 3 0.0001
925 DYSGEUSIA 5 0.0001
926 HAEMORRHAGE 7 0.0001
927 THROAT IRRITATION 3 0.0001
928 BLOOD POTASSIUM DECREASED 2 0.0001
929 PREMATURE BABY 2 0.0001
930 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
931 DISCOMFORT 4 0.0001
932 SKIN DISCOLOURATION 3 0.0001
933 EMOTIONAL DISORDER 2 0.0001
934 EXPOSURE DURING PREGNANCY 4 0.0001
935 INFLUENZA 7 0.0001
936 MOOD SWINGS 2 0.0001
937 BLOOD GLUCOSE DECREASED 3 0.0001
938 NIGHT SWEATS 2 0.0001
939 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
940 IMPAIRED HEALING 2 0.0001
941 INFLUENZA LIKE ILLNESS 5 0.0001
942 FUNGAL INFECTION 2 0.0001
943 DISEASE PROGRESSION 7 0.0001
944 FLUID RETENTION 3 0.0001
945 HEPATIC ENZYME INCREASED 4 0.0001
946 SINUSITIS 6 0.0001
947 PRODUCT USE ISSUE 11 0.0001
948 MUSCULOSKELETAL PAIN 3 0.0001
949 RASH MACULAR 2 0.0001
950 BURNING SENSATION 4 0.0001
951 CEREBRAL HAEMORRHAGE 2 0.0001
952 DRUG EFFECT DECREASED 3 0.0001
953 HAEMATOCHEZIA 3 0.0001
954 EYE SWELLING 2 0.0001
955 ASTHMA 6 0.0001
956 EYE IRRITATION 3 0.0001
957 COVID-19 9 0.0001
958 ALOPECIA 10 0.0001
959 DYSPEPSIA 5 0.0001
960 STOMATITIS 3 0.0000
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
962 DEVICE BREAKAGE 2 0.0000
963 FEELING HOT 3 0.0000
964 NASOPHARYNGITIS 9 0.0000
965 INCORRECT DOSE ADMINISTERED 11 0.0000
966 ROAD TRAFFIC ACCIDENT 2 0.0000
967 DEATH 41 0.0000
968 SWELLING FACE 3 0.0000
969 PSORIASIS 6 0.0000
970 MUSCULOSKELETAL STIFFNESS 4 0.0000
971 INFUSION RELATED REACTION 3 0.0000
972 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
973 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
974 BREAST CANCER 4 0.0000
975 JOINT SWELLING 5 0.0000
976 CELLULITIS 2 0.0000
977 INJECTION SITE SWELLING 3 0.0000
978 RENAL IMPAIRMENT 3 0.0000
979 EYE PAIN 2 0.0000
980 NASAL CONGESTION 2 0.0000
981 OROPHARYNGEAL PAIN 3 0.0000
982 INJECTION SITE ERYTHEMA 4 0.0000
983 FEBRILE NEUTROPENIA 2 0.0000
984 INJECTION SITE REACTION 2 0.0000
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
986 PERIPHERAL SWELLING 4 0.0000
987 INJECTION SITE BRUISING 2 0.0000
988 CARDIAC FAILURE 2 0.0000
989 DRY SKIN 3 0.0000
990 NO ADVERSE EVENT 4 0.0000
991 ADVERSE EVENT 2 0.0000
992 INJECTION SITE PAIN 6 0.0000
993 DRUG DOSE OMISSION 2 0.0000